Table 1 Relationships between the expression of INHα and clinicopathological parameters in prostate adenocarcinoma (n=37)
Benign regions | Cancer regions (G3/G4) | Stromal regions | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Parameters | No. of specimens | Mean intensity | Relative risk (95% CI) | P -value | Mean intensity | Relative risk (95% CI) | P -value | Mean intensity | Relative risk (95% CI) | P -value |
Combined Gleason grade | ||||||||||
6 | 16 | 0.7 | NA | 1.88 | NA | 0.30 | NA | |||
7 | 14 | 1.51 | NA | 2.21 | NA | 1.21 | NA | |||
⩾8 | 7 | 1.29 | NA | 1.99 | NA | 2.00 | NA | |||
Extracapsular spread | ||||||||||
Positive | 24 | 1.43 | 2.13 | 1.41 | ||||||
Negative | 13 | 0.65 (reference) | 2.07 (1.04–4.13) | 0.01a | 1.87 (reference) | 1.27 (0.76–2.11) | NSa | 0.08 (reference) | 2.55 (1.39–4.65) | 0.0011a |
Surgical margins | ||||||||||
Positive | 16 | 1.15 | 1.84 | 1.47 | ||||||
Negative | 21 | 1.12 (reference) | 1.15 (0.68–3.08) | NSa | 2.18 (reference) | 0.71 (0.32–1.53) | NSa | 0.50 (reference) | 4.75 (1.62–13.93) | 0.0006a |
VEGFR-3+ vessels | ||||||||||
Positive | 18 | 1.29 | 2.07 | 1.53 | ||||||
Negative | 19 | 0.97 (reference) | 1.27 (0.62–2.60) | NSa | 2.00 (reference) | 1.20 (0.0–2.39) | NSa | 0.33 (reference) | 2.85 (1.28–6.37) | 0.0067a |
Lymph node metastasis | ||||||||||
Positive | 16 | 1.41 | 2.06 | 1.93 | ||||||
Negative | 21 | 1.01 (reference) | 1.62 (0.67–3.97) | NSa | 2.00 (reference) | 0.84 (0.48–1.46) | NSa | 0.15 (reference) | 13.22 (1.94–90.00) | <0.0001a |